Abstract:Quant Imaging Med Surg 2021;11(2):870-875 | http://dx.doi.org/10.21037/qims-20-1253 In our recent study using a rat model of non-alcoholic fatty liver disease (NAFLD) induced with methionine and choline-deficient (MCD) diet, we demonstrated that collagen deposition in the liver strongly contribute to liver T1rho elongation, while fat deposition contributes to T1rho shortening (1,2). However, there were two questions remain unanswered. The first is that how the fat content’s contribution to T1rho shortening can be quantified. Secondly, since we estimated that 1% collagen area increase contributed to T1rho value increase of 1.35 ms, and this observation might have been damped by that fat deposition always co-existed with collagen deposition in this animal model, thus it remains undetermined that 1% collagen increase contributes to how much T1rho value elongation in the absence of liver steatosis. Hereby we try to address these two questions. Using last study’s data of each experimental rat’s collagen content (in percentage area measured with histology), MRI measured fat content (in percentage), and T1rho (in ms, millisecond), we ranked the results according to the collagen content and selected the 15 pairs where the collagen content difference within each pair was ≤0.03%. Since liver collagen content of experimental rats measured from 0.34– 6.46% (mean ± SD: 2.58%±1.54%), the within pair collagen content difference of these rats could be considered to be ‘zero’ (1). We took the assumption that, in our MCD model, inflammation’s contribution to T1rho per se was minimal, and was instead mediated via collagen deposition. Thus, leaving aside the issue of measurement imprecision, we can hypothesize that difference between each pair’s liver T1rho value was primarily due to the difference in liver fat content. Note we confirmed that liver fat content measured by MRI was almost the same as measured by histology (1). Figure 1A shows, when disregarding the amount of fat content difference, higher liver fat content is seen with longer liver T1rho value in 5 pairs while with shorter T1rho value in 10 pairs. The mean difference among the 15 pairs was −1.028 (95% confidence interval: −1.9499, −0.1061, P=0.031). The mean difference value of 10 pairs with T1rho shortening was three times of that of the 5 pairs with T1rho elongation (−1.874 vs. 0.664 ms). A mean of 8.72% higher fat content was associated with a mean of 1.03 ms T1rho shortening (data from Figure 1A). A linear regression suggests 10% fat increase contributed to 1.55 ms T1rho shortening (Figure 1B, Pearson r=−0.40). We hypothesize that higher Letter to the Editor

Impact of Liver Fibrosis and Fatty Liver on T1rho Measurements: A Prospective Study.

T1rho Shortening Effect of Fat in Liver Steatosis after Fat Suppression: Approximate Estimation in a Methionine and Choline-Deficient (MCD) Diet Rat Model.

Collagen Deposition in the Liver is Strongly and Positively Associated with T1rho Elongation While Fat Deposition is Associated with T1rho Shortening: an Experimental Study of Methionine and Choline-Deficient (MCD) Diet Rat Model.

T1 Mapping, T2 Mapping and MR Elastography of the Liver for Detection and Staging of Liver Fibrosis.

Assessment of Liver Fibrosis by Variable Flip Angle T-1 Mapping at 3.0T

Comparison of T2, T1rho, and diffusion metrics in assessment of liver fibrosis in rats.

Diffusion-weighted Imaging and Variable Flip Angle T1 Mapping: a Supplement for Image-Guided Biopsy in Follow-Up Analysis of Liver Fibrosis

T1ρ magnetic resonance imaging for liver fibrosis detection and staging

Liver injury monitoring, fibrosis staging and inflammation grading using T1rho magnetic resonance imaging: an experimental study in rats with carbon tetrachloride intoxication

Quantitative Assessment of Liver Function with Whole-Liver T1rho Mapping at 3.0T.

MRI Dixon Fat-Corrected Look-Locker T1 Mapping for Quantification of Liver Fibrosis and Inflammation—A Comparison With the Non–Fat-Corrected Shortened Modified Look-Locker Inversion Recovery Technique

Advance of MRI T1ρ in Evaluation of Liver Fibrosis

Staging Liver Fibrosis: Comparison of Native T1 Mapping, T2 Mapping, and T1ρ: an Experimental Study in Rats with Bile Duct Ligation and Carbon Tetrachloride at 11.7 T MRI

Assessment of Liver Fibrosis Using Pharmacokinetic Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Measurement of Liver T1 and T2 Relaxation Times in an Experimental Mouse Model of Liver Fibrosis

Staging liver fibrosis in chronic hepatitis B with T relaxation time index on gadoxetic acid-enhanced MRI: Comparison with aspartate aminotransferase-to-platelet ratio index and FIB-4.

MR T1ρ As an Imaging Biomarker for Monitoring Liver Injury Progression and Regression: an Experimental Study in Rats with Carbon Tetrachloride Intoxication.

Assessment of Liver Fibrosis Using T1 Mapping on Gd-EOB-DTPA-enhanced Magnetic Resonance.

Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk

Combined morphological and functional liver MRI using spin-lattice relaxation in the rotating frame (T1ρ) in conjunction with Gadoxetic Acid-enhanced MRI

Integrated quantitative susceptibility and R2 * mapping for evaluation of liver fibrosis: An ex vivo feasibility study